Name: Pilosol 30mg
Brand: ZISKA PHARMACEUTICALS
SKU: 8794
Availability: InStock

Pilosol 30mg

৳ 160

Indications

Internal and external hemorrhoids, anal pruritus, anal eczema, anitis, perianitis, acute hemorrhoidal thrombosis and anal fissure. Pre and postoperative treatment in cases of hemorrhoidectomy. A long-lasting treatment is not indicated.

Dosage & Administration

2 -3 times daily. Apply in the morning and bedtime and if possible after defecation. If the ointment is preferred, use the applicator by screwing it to the tube. Insert the applicator as deep as possible in the anus then press the tube gently while withdrawing it. In this case, the tube is sufficient for 8 applications. In case of external hemorrhoids or anal pruritus, apply a thin layer of the ointment several times a day. The duration of the treatment is generally of some days. The doctor must be informed if, after 1 to 2 weeks of treatment, the symptomatology has not improved or has worsened.

Side Effects

Precautions

In case of renal insufficiency, Pilosol should not be used during longer periods. Avoid long-lasting treatments.

Contraindications

Hypersensitivity towards the components of Pilosol.

Use in Pregnancy & Lactation

Pregnancy category C

Studies in pregnant women or animals are not available and in humans, it is not known whether Calcium Dobesilate crosses the placental barrier. On the other hand, after topical administration, Lidocaine Hydrochloride and Dexamethasone Acetate are resorbed in variable quantities and can have systemic effects. Moreover, both substances cross the placental barrier. In these conditions, Pilosol should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus.

After oral administration, Calcium Dobesilate is excreted in the maternal milk in low amounts but it is not known whether this is the case with local use. After topical administration, Lidocaine Hydrochloride and Dexamethasone Acetate are excreted in the maternal milk. As a precaution, it should be decided between discontinuating the treatment or the breast-feeding.